Frequency of infectious agents for vaginitis in patients with a cytological diagnosis of atypical squamous cells of undetermined significance

Aim: To evaluate the presence of infectious agents for vaginitis in patients with ASCUS. Methods: 33,388 patients who underwent cervical-vaginal cytology from 08/1993 to 05/2002 were included in the study, and 1,104 (3.4%) presented positive ASCUS. The appraised infectious agents were Coccobacilli, Candida sp, Trichomonas vaginalis, and clue cells (Gardnerella vaginalis). Results: In the group with ASCUS a larger frequency of Coccobacilli (22.37%) and Trichomonas vaginalis (5.25%) was found when compared with the group with negative ASCUS (17.79% and 3.98%, respectively; p < 0.05). Cytolysis occurred more frequently in patients with ASCUS (3.8 vs 6.3%, first phase and 4.5 vs 10%, second phase). Conclusions: We believe that some diagnoses of ASCUS can be induced by the presence of infectious agents for vaginitis, mainly cocci and coccoides. ASCUS occurs more frequently in the first phase of the menstrual cycle, therefore in less acid vaginal pH.

ASCUS; Infectious agents; Vaginitis; Papanicolaou smears

[1] National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal diagnosis. J. Am. Med. Assoc., 1989, 262, 931.

[2] Davey D.D., Nielsen M.L., Naryshkin S., Robb J.A., Cohen T., Kline T.S.: “Atypical squamous cells of undetermined significance”. Arch. Pathol. Lab. Med., 1996, 120, 440.

[3] Ergeneli M.H., Duran E.H., Ergini T., Demirhan B., Erdogen M.: “Atypical squamous cells of undetermined significance clinical experience in a Turkish university hospital”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 96, 108.

[4] Kurman R.J., Henson D.E., Herbst A.L., Noller K.L., Schiffman M.H.: “Interim guidelines for management of abnormal cervical cytology”. JAMA, 1994, 271, 1886.

[5] Sherman M.E., Schiffman M.H., Erozan Y.S., Wacholder S., Kurman R.J.: “The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytologic diagnosis”. Arch. Pathol. Lab. Med., 1992, 116, 1155.

[6] Adad S.J., Lima V.R., Sawan Z.T.E., Silva M.L.G., Souza M.A.H., Saldanha J.C. et al.: “Frequency of Trichomonas vaginalis, Candida sp, and Gardnerella vaginalis in cervical-vaginal smears in four different decades”. São Paulo Med. J., 2001, 119, 200.

[7] Mirza N.B., Nsanze H., D’Costa L.J., Piot P.: “Microbiology of vaginal discharge in Nairobi, Kenya”. Br. J. Vener. Dis., 1983, 59, 186.

[8] Oyarzún E.E., Poblete A.L., Montiel F.A., Gutiérrez P.H.: “Vaginosis bacteriana: diagnostico y prevalencia”. Chil. Obstet. Gynecol., 1996, 61, 28.

[9] Ray A., Gulati A.K., Pandey L.K., Pandey S.: “Prevalence of common infective agents of vaginitis”. J. Commun. Dis., 1989, 21, 241.

[10] Rivera L.R., Trenado M.Q., Valdez A.C., Gonzalez C.J.C.: “Prevalencia de vaginits y vaginosis bacteriana: associación com manifestaciones clínicas de laboratório y tratamiento”. Ginec. y Obstet. Mex., 1996, 64, 26.

[11] Rossi G.G., Mendoza M.: “Incidencia de tricomoniasis vaginal em la consulta externa de ginecologia”. Bol. Méd. postgrado, 1996, 12, 34.

[12] Toloi M.R.T., Franceschini A.S.: “Exames colposcópicos de rotina: Aspectos laboratoriais e patológicos”. J. Bras. Ginec., 1997, 107, 251.

[13] Hart G.: “Factors associated with trichomoniasis, candidiasis and bacterial vaginosis”. Int. J. STD AIDS, 1992, 4, 21.

[14] Konje J.C., Otolorin E.O., Ogunniyi J.O., Obisesan K.A., Ladipo A.O.: “The prevalence of Gardenerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria”. Afr. J. Med. Sci., 1991, 20, 29.

[15] Murta E.F.C., Souza M.A., Araújo Junior E., Adad S.J.: “Incidence of Gardnerella vaginalis, Candida sp and human papilloma virus in cytological smears”. São Paulo Med. J., 2001, 118, 105.

[16] Murta E.F.C., Silva A.O., Silva E.A.C., Adad S.J: “Frequêncy of infectious agents for vaginitis in non-and hysterectomized women”. Arch. Gynecol. Obstet., 2005, 273, 152.

[17] Murta E.F.C, Barcelos A.C.M.: “Relation between vaginal an endocervical pH in pre and post-menopausal women”. Arch. Gynecol. Obstet., 2005, 272, 211.

[18] Barcelos A.C.M., Adad S.J., Michelin M.A., Murta E.F.C.: “Atypical squamous cells of undetermined significance: Analysis of microbiology, cytological criteria and clinical correlate”. Tumori, 2006, 92, 214.

[19] Gupta P.K.: “Microbiology, inflammation, and viral infections”. In: Bibbo M. (ed.): “Comprehensive Cytopathology”. Phila delphia, WB Saunders, 1997, 125.

[20] Solomon D.: “The Bethesda system for cervicovaginal cytopathology”. In: Bibbo M. (ed.): “Comprehensive Cytopathology”. Philadel phia: WB Saunders, 1997, 93.

[21] Wied G.L., Bibbo M.: “Hormonal cytology”. In: Bibbo M. (ed.): “Comprehensive Cytopathology”. Philadelphia, WB Saunders Company, 1997, 101.

[22] Miguel N.L., Lachowicz C.M., Kline T.S.: “Candida-related changes and ASCUS: a potential trap!”. Diagn. Cytopathol., 1996, 16, 83.

[23] Solomon D., Davey D., Kurman R., Moriarty A., O’Connor D., Prey M. et al.: “The 2001 Bethesda System: terminology for reporting results of cervical cytology”. JAMA, 2002, 287, 2114.

[24] Nugent R.P., Khrohn M.A., Hillier S.L.: “Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation”. J. Clin. Microbiol., 1991, 29, 297.

[25] Giacomini G., Calcinai A., Moreti D., Cristofani A.R.: “Accuracy of cervical/vaginal cytology in the diagnosis of bacterial vaginosis”. Sex. Trans. Dis., 1998, 25, 24.

[26] Caillouette, J.C., Sharp, C.F. Jr., Zimmerman, G.J., Roy S.:“ Vaginal pH as a marker for bacterial pathogens and menopausal status”. Am. J. Obstet. Gynecol., 1997, 176, 1270.

[27] ASCUS-LSIL Triage Study (ALTS) Group. “Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance”. Am. J. Obstet. Gynecol., 2003, 188, 1383.